跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9 条关于
“QUELIMMUNE”
全部
9
临床试验
1
药物
0
机构
1
资讯
7
上个月
SeaStar Medical Reports 82% QUELIMMUNE Revenue Growth as NEUTRALIZE-AKI Trial Advances Toward Adult AKI Indication
9个月前
FDA Reduces Surveillance Requirements for SeaStar Medical's Pediatric AKI Therapy Following Promising Safety Data
2年前
SeaStar Medical Secures $3.6 Million NIH Grant for Heart Failure Device Study
去年
SeaStar Medical's AKI Trial Gains Momentum with Stanford Enrollment and Milestone Achievement
去年
SeaStar Medical's SCD Shows Multibillion-Dollar Market Potential Across Multiple Indications
去年
SeaStar Medical's SCD Therapy Receives $2 Million DoD Grant for Military Burn and Sepsis Research
去年
SeaStar Medical Reaches Halfway Enrollment Milestone in Pivotal NEUTRALIZE-AKI Trial for Acute Kidney Injury